XML 74 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details) (Optimer Pharmaceuticals, Inc., USD $)
Sep. 30, 2013
Oct. 24, 2013
Subsequent event
right
Oct. 24, 2013
Subsequent event
Maximum
Subsequent events      
Cash consideration   $ 550,500,000  
Purchase price of outstanding common stock of acquiree (in dollars per share)   $ 10.75  
Number of transferable contingent value rights receivable by stockholders of acquiree   1  
Maximum additional cash payment per share (in dollars per share)   $ 5.00  
Undiscounted contingent consideration     253,900,000
Percentage of outstanding shares acquired   100.00%  
Transaction costs $ 3,900,000